HomeBiotech

Biotech

Ryvu Therapeutics Reports 2024 Half-Year Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports 2024 Half-Year Financial Results and Provides Corporate Update

September 12, 2024

Biolexis Unveils Promising Data with an Oral Weight Loss Drug: BLX-7006 Shows Significant Results in Preclinical Studies

Biolexis Unveils Promising Data with an Oral Weight Loss Drug: BLX-7006 Shows Significant Results in Preclinical Studies

September 12, 2024

Viatris Announces Expiration and Results of Any and All Cash Tender Offers

Viatris Announces Expiration and Results of Any and All Cash Tender Offers

September 11, 2024

Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue

Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue

September 11, 2024

NETRAMARK EXPANDS PRODUCT OFFERINGS TO ADDRESS CORE CLINICAL TRIAL CHALLENGES AND IMPROVE MARKET ACCESS SUCCESS

NETRAMARK EXPANDS PRODUCT OFFERINGS TO ADDRESS CORE CLINICAL TRIAL CHALLENGES AND IMPROVE MARKET ACCESS SUCCESS

September 11, 2024

MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology

MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology

September 9, 2024

GC Biopharma Launches ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults, an Immune Globulin for the Treatment of Primary Humoral Immunodeficiency (PI) – Now Available in the US Marketplace

GC Biopharma Launches ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults, an Immune Globulin for the Treatment of Primary Humoral Immunodeficiency (PI) – Now Available in the US Marketplace

September 9, 2024

Lyophilized Reagent Beads Market Size to Grow USD 380 Million by 2030 at a CAGR of 11.0% | Valuates Reports

Lyophilized Reagent Beads Market Size to Grow USD 380 Million by 2030 at a CAGR of 11.0% | Valuates Reports

September 8, 2024

Florida Cancer Specialists & Research Institute Leverages Real-World Evidence Capabilities To Advance Blood Cancer Treatment

Florida Cancer Specialists & Research Institute Leverages Real-World Evidence Capabilities To Advance Blood Cancer Treatment

September 7, 2024

FDA Roundup: September 6, 2024

FDA Roundup: September 6, 2024

September 7, 2024

« 1 … 15 16 17 18 19 … 75 »